Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Clin Neuropsychol ; 37(4): 729-737, 2022 May 16.
Article in English | MEDLINE | ID: mdl-35136912

ABSTRACT

OBJECTIVE: A subset of individuals with coronavirus disease 2019 (COVID-19) appears to develop persisting cognitive and medical symptoms. Research in the acute stages of illness, generally utilizing cognitive screening measures or case reports, suggests presence of deficits in attention and executive function. This observational study investigated cognitive functioning among individuals with persistent cognitive complaints about 5.5 months after COVID-19 infection. METHODS: Patients with polymerase chain reaction confirmed COVID-19 and persistent cognitive complaints underwent comprehensive in-person neuropsychological evaluations. Patients with prior neurological disorders were excluded. When diagnosed, 40% required hospitalization, 15% were in an intensive care unit, 10% needed mechanical ventilation, and 10% experienced delirium. RESULTS: This sample was predominately women (90%), White non-Hispanic (70%), with average education of 15 years. Mild cognitive deficits were seen on tests involving attention and processing speed or executive function. Seventy percent of patients were diagnosed with a mood disorder prior to COVID-19 infection. At the time of testing, 35%-40% endorsed moderate to severe mood symptoms and 85% noted significant fatigue as measured by the Fatigue Severity Scale. CONCLUSIONS: The pattern of cognitive deficits, although mild, is consistent with prior research at the acute stage of the illness. These findings suggest that psychological factors and other persisting symptoms (e.g., sleep, fatigue) may play a significant role in subjective cognitive complaints in patients with persisting complaints post COVID-19 who did not require intensive treatment. These patients would likely benefit from resources to manage persisting or new mood symptoms and compensatory strategies for the cognitive inefficiencies they experience.


Subject(s)
COVID-19 , Cognition Disorders , COVID-19/complications , Cognition , Cognition Disorders/complications , Cognition Disorders/etiology , Fatigue , Female , Humans , Neuropsychological Tests
2.
Int J Mol Sci ; 22(7)2021 Mar 31.
Article in English | MEDLINE | ID: mdl-33807153

ABSTRACT

Soil salinity is an increasing problem facing agriculture in many parts of the world. Climate change and irrigation practices have led to decreased yields of some farmland due to increased salt levels in the soil. Plants that have tolerance to salt are thus needed to feed the world's population. One approach addressing this problem is genetic engineering to introduce genes encoding salinity, but this approach has limitations. Another fairly new approach is the isolation and development of salt-tolerant (halophilic) plant-associated bacteria. These bacteria are used as inoculants to stimulate plant growth. Several reports are now available, demonstrating how the use of halophilic inoculants enhance plant growth in salty soil. However, the mechanisms for this growth stimulation are as yet not clear. Enhanced growth in response to bacterial inoculation is expected to be associated with changes in plant gene expression. In this review, we discuss the current literature and approaches for analyzing altered plant gene expression in response to inoculation with halophilic bacteria. Additionally, challenges and limitations to current approaches are analyzed. A further understanding of the molecular mechanisms involved in enhanced plant growth when inoculated with salt-tolerant bacteria will significantly improve agriculture in areas affected by saline soils.


Subject(s)
Halobacteriales/metabolism , Plant Development/genetics , Plants/genetics , Plants/microbiology , Salt Tolerance/genetics , Salt-Tolerant Plants/metabolism , Bacteria/metabolism , Gene Expression , Genes, Plant , Plant Roots/metabolism , Salinity , Soil/chemistry , Soil Microbiology
3.
Neuropsychology ; 33(2): 212-221, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30589284

ABSTRACT

OBJECTIVE: Among patients with brain damage, executive function deficits and impulsivity correspond with propensity to engage in risky behaviors. Less research has addressed this issue in healthy adults, and fewer still have simultaneously evaluated the importance of executive function and impulsive personality. Additionally, most research has focused exclusively on substance use while ignoring other domains of risky behavior such as sexual activity and antisocial practices. Toward this end, we examined the association of risky behaviors with executive function and self-reported impulsivity. METHOD: Healthy undergraduates (n = 56) were administered the Iowa Gambling Task (IGT), Wisconsin Card Sorting Test (WCST), and UPPS-P impulsivity questionnaire. A self-report questionnaire assessed risky sexual activities, drug use, and antisocial behaviors over a 2-month interval. RESULTS: After accounting for social desirability and performance effort, multiple regression analyses revealed a robust relationship between executive function and risk-taking. Specifically, WCST performance correlated with risky sexual and substance use behavior, whereas the IGT was uniquely linked with antisocial acts. Trait impulsivity was positively associated with sexual behavior. CONCLUSIONS: Extending previous research, executive function accounted for more variance in risky behaviors than self-reported impulsivity, but this was mediated by facet of executive function. Decision-making under risk seemed to better account for antisocial acts, whereas perseveration was more strongly linked to sexual activity and substance misuse. These data imply that poor executive function increases the likelihood that healthy young adults will engage in risky and potentially dangerous acts, extending the ecological validity of the WCST and IGT. (PsycINFO Database Record (c) 2019 APA, all rights reserved).


Subject(s)
Decision Making/physiology , Executive Function/physiology , Impulsive Behavior/physiology , Risk-Taking , Adolescent , Female , Humans , Male , Neuropsychological Tests , Personality/physiology , Self Report , Students , Surveys and Questionnaires , Young Adult
4.
J Clin Exp Neuropsychol ; 36(8): 887-96, 2014.
Article in English | MEDLINE | ID: mdl-25338929

ABSTRACT

Prospective memory (PM) pertains to the execution of a future goal or behavior. Initial research implies that people with multiple sclerosis (MS) are apt to show impaired prospective memory for activities of daily living. Yet, PM impairment does not occur in all people with MS. Thus, some other variable besides disease status alone may contribute to PM dysfunction in people with MS. Chronic pain may be such a variable. Approximately 50-70% of people with MS experience significant pain, and such pain has been thought to diminish memory function. To investigate this possibility, 96 patients with MS and 29 healthy subjects were administered the Memory for Intentions Screening Test (MIST; Woods, S. P., Iudicello, J. E., Moran, L. M, Carey, C. L., Dawson, M. S., & Grant, I. (2008). HIV-associated prospective memory impairment increases risk of dependence in everyday functioning. Neuropsychology, 22, 110-117.), a well-validated measure of prospective memory, and the Medical Outcomes Study Pain Effects Scale (PES; Fischer, J. S., Rudick, R. A., Cutter, G. R., & Reingold, S. C. (1999). The multiple sclerosis functional composite measure (MSFC): An integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Multiple Sclerosis, 5, 244-250.) to assess chronic pain. After controlling for demographic variables and disability severity, subjective pain accounted for significant variance in PM, particularly for time-based intentions over sustained delay periods. These data accord well with assertions that pain may degrade ability to remember new intentions and suggests that pain is associated with PM dysfunction in people with MS.


Subject(s)
Memory Disorders/etiology , Memory, Episodic , Multiple Sclerosis/complications , Pain/etiology , Activities of Daily Living , Adult , Depression/etiology , Female , Humans , Male , Middle Aged , Multiple Sclerosis/psychology , Neuropsychological Tests , Quality of Life , Regression Analysis , Self Report
SELECTION OF CITATIONS
SEARCH DETAIL
...